Cargando…
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
Low-dose naltrexone (LDN) has been demonstrated to reduce symptom severity in conditions such as fibromyalgia, Crohn’s disease, multiple sclerosis, and complex regional pain syndrome. We review the evidence that LDN may operate as a novel anti-inflammatory agent in the central nervous system, via ac...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer London
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962576/ https://www.ncbi.nlm.nih.gov/pubmed/24526250 http://dx.doi.org/10.1007/s10067-014-2517-2 |